Novo launched the pill in the US in January 2026 after winning FDA approval in December 2025, giving it a significant head start in what analysts expect to be a $150bn-a-year market within a decade
Both medications offer a wide range of long-term health improvements, including: Improved blood sugar control : Both drugs help manage blood sugar levels in people with type 2 diabetes, which can prevent complications like neuropathy, kidney disease, and vision loss
Cancer patients must only take milk thistle preparations after explicit consultation with their treating oncologist
The in vivo study showed a significant reduction in TMAO levels in C57BL/6(FMO3 +/+ ) strain WT mouse models and in TMA levels in C57BL/6 -Fmo3em1Smoc (KO) mouse models
Acknowledgments Authors would like to thank Dr
On average, GFR decreased during QSYMIA treatment and returned to baseline within 4 weeks after discontinuing QSYMIA [see Warnings and Precautions (5.8)]